Clinical Trial Update: Intratumoral PH-762 for Cutaneous Carcinoma [Phase 1]

View source ↗

Summary

PH-762 is being evaluated in a Phase 1 intratumoral trial for cutaneous carcinomas, with the study currently listed as active but not recruiting. Conditions inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma of the Skin
• Merkel Cell Carcinoma
• Squamous Cell Carcinoma of the Skin

Drugs mentioned

• PH-762

Snippet

Sponsor: Phio Pharmaceuticals Inc. | Conditions: Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin | Phase 1 | Status: ACTIVE_NOT_RECRUITING